TSS
BMY icon

Two Sigma Securities’s Bristol-Myers Squibb BMY Stock Holding History

Two Sigma Securities’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-201,900
Closed -$10.4M – 1789
2024
Q3 		$10.4M Sell
201,900
-184,600
-48% -$8.66M 0.18% 151
2024
Q2 		$16.1M Buy
386,500
+150,300
+64% +$6.73M 0.19% 106
2024
Q1 		$12.8M Sell
236,200
-77,500
-25% -$3.95M 0.12% 190
2023
Q4 		$16.1M Buy
313,700
+122,000
+64% +$6.4M 0.16% 138
2023
Q3 		$11.1M Buy
191,700
+139,600
+268% +$8.55M 0.12% 185
2023
Q2 		$3.33M Sell
52,100
-6,000
-10% -$402K 0.05% 411
2023
Q1 		$4.03M Sell
58,100
-38,200
-40% -$2.69M 0.08% 296
2022
Q4 		$6.93M Buy
96,300
+46,700
+94% +$3.52M 0.21% 94
2022
Q3 		$3.53M Buy
49,600
+2,600
+6% +$189K 0.11% 226
2022
Q2 		$3.62M Sell
47,000
-11,700
-20% -$891K 0.13% 172
2022
Q1 		$4.29M Buy
58,700
+52,400
+832% +$3.52M 0.15% 155
2021
Q4 		$393K Buy
6,300
+2,100
+50% +$123K 0.02% 664
2021
Q3 		$249K Sell
4,200
-28,900
-87% -$1.9M 0.01% 1100
2021
Q2 		$2.21M Buy
33,100
+23,000
+228% +$1.5M 0.07% 216
2021
Q1 		$638K Sell
10,100
-41,100
-80% -$2.56M 0.04% 233
2020
Q4 		$3.18M Buy
51,200
+31,400
+159% +$1.93M 0.08% 165
2020
Q3 		$1.19M Sell
19,800
-35,600
-64% -$2.14M 0.02% 308
2020
Q2 		$3.26M Sell
55,400
-68,300
-55% -$4.09M 0.07% 150
2020
Q1 		$6.89M Sell
123,700
-176,400
-59% -$10.8M 0.16% 77
2019
Q4 		$19.3M Buy
300,100
+107,100
+55% +$6.13M 0.13% 107
2019
Q3 		$9.79M Sell
193,000
-73,500
-28% -$3.45M 0.09% 168
2019
Q2 		$12.1M Buy
266,500
+255,600
+2,345% +$11.9M 0.13% 102
2019
Q1 		$520K Sell
10,900
-66,900
-86% -$3.33M ﹤0.01% 856
2018
Q4 		$4.04M Sell
77,800
-19,300
-20% -$1.04M 0.05% 196
2018
Q3 		$6.03M Sell
97,100
-218,900
-69% -$13M 0.04% 329
2018
Q2 		$17.5M Buy
316,000
+17,400
+6% +$940K 0.09% 167
2018
Q1 		$18.9M Buy
298,600
+274,100
+1,119% +$17.6M 0.11% 163
2017
Q4 		$1.5M Buy
+24,500
New +$1.53M 0.04% 326

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Securities's BMY Position: Q4 2025 in Review

Two Sigma Securities sold out of Bristol-Myers Squibb (BMY) in Q4 2025, closing a stake of 43,983 shares — an estimated $1.98M sold.

Two Sigma Securities first reported a position in BMY in Q4 2016 and held it in 28 quarters. The position peaked at $18.8M in Q3 2023. 2,447 funds tracked by Wall St. Rank hold BMY as of Q4 2025.

  • Two Sigma Securities reported no remaining Bristol-Myers Squibb position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 43,983 Bristol-Myers Squibb shares in Q4 2025, an estimated $1.98M.
  • Two Sigma Securities first reported a position in Bristol-Myers Squibb in Q4 2016 and held it in 28 quarters.
  • Two Sigma Securities's Bristol-Myers Squibb position peaked at $18.8M in Q3 2023.
  • 2,447 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.